University of Texas/Texas AM Investment Management Co (UTIMCO)’s Alto Neuroscience ANRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$585K Hold
22,175
0.07% 111
2026
Q1
$498K Hold
22,175
0.07% 112
2025
Q4
$395K Hold
22,175
0.06% 133
2025
Q3
$89.1K Hold
22,175
0.01% 133
2025
Q2
$48.8K Hold
22,175
0.01% 128
2025
Q1
$47.9K Hold
22,175
0.01% 128
2024
Q4
$93.8K Hold
22,175
0.01% 120
2024
Q3
$254K Hold
22,175
0.04% 87
2024
Q2
$237K Hold
22,175
0.05% 103
2024
Q1
$340K Buy
+22,175
New +$347K 0.07% 78

Other funds holding ANRO

University of Texas/Texas AM Investment Management Co (UTIMCO)'s ANRO Position: Q2 2026 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) held its Alto Neuroscience (ANRO) position steady in Q2 2026 at 22,175 shares worth $585K. The position accounts for 0.07% of the portfolio, ranked #111.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in ANRO in Q1 2024 and has held it in 10 quarters since. 49 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) held 22,175 shares of Alto Neuroscience worth $585K as of Q2 2026.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) left its Alto Neuroscience share count unchanged in Q2 2026.
  • Alto Neuroscience made up 0.07% of University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio in Q2 2026, its #111 holding.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Alto Neuroscience in Q1 2024 and has held it in 10 quarters since.
  • 49 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2026, filed 3 Aug 2026.